Announced on its homepage: “Learn more about us Supporters Previous Next Bi/ond secures over $4M in funding March 8, 2022 Organ-on-a-chip success with leading Europe…”.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
BI/OND | Versatile organ on chip platform My title
BI/OND the versatile Organ-on -chip platform. BI/OND Empowers biologists with hardware solutions for cell-based assays. BI/OND’s customizable Organ-on-Chips (OOCs) are built to outperform the limitati
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
February 2024 – January 2026 · 3 captures · latest observed messagingRevolutionary Cell Research Technology from Bi/ond
Cell research technology: recreate key aspects of human organs, like beating of a heart, tissue interactions or blood circulation.
October 2018 – August 2019 · 2 capturesBI/OND | Versatile organ on chip platform My title
BI/OND the versatile Organ-on -chip platform. BI/OND Empowers biologists with hardware solutions for cell-based assays. BI/OND’s customizable Organ-on-Chips (OOCs) are built to outperform the limitati